Aflibercept formulations and uses thereof

Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.

Saved in:
Bibliographic Details
Main Authors Siska, Christine C, Kerwin, Bruce A, Floyd, Julee A, Gillespie, Alison J
Format Patent
LanguageEnglish
Published 11.06.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ophthalmic formulations comprising aflibercept are disclosed that are suitable for a method of treatment of an eye disorder or disease by intravitreal or topical administration.
Bibliography:Application Number: US202117492649